Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

this weeks' manuscripts on covid-19 & psoriasis

Related Articles

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Dermatol Ther (Heidelb). 2020 May 29;:

Authors: Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W

The outbreak of the novel coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 was first reported in late December 2019. Many patients with psoriasis on biologic therapy have asked their medical providers about the effect of biologics on COVID-19. However, it is currently unknown how biologic therapy for psoriasis might impact patients with psoriasis and COVID-19. In this article, we report on the clinical course of two patients on biologic medication for psoriasis who developed COVID-19 and successfully recovered from SARS-CoV-2 infection. Both patients presented with fever and respiratory symptoms, but neither patient required hospitalization. While more research is needed, it is reassuring to know that successful recovery is possible after COVID-19 infection in patients on biologic therapy for psoriasis.

PMID: 32468230 [PubMed - as supplied by publisher]


Other relevant manuscripts
IPC's Chief Medical Officer has selected the following manuscripts as important to the understanding of the impact of COVID-19 and psoriasis. 

selections for week of may 18, 2020 

The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A metaestimate of pivotal trials relevant to decision-making during the COVID-19 pandemic.  Wan MT, Shin DB, Winthrop KL, Gelfand JM. Journal of the American Academy of Dermatology. 2020. doi:

Practice guidelines for teledermatology in Australia. Abbott LM, Miller R, Janda M, Bennett H, Taylor M, Arnold C, Shumack S, Soyer HP, Caffery LJ. Australas. J Dermatol. 2020 May 3. doi: 10.1111/ajd.13301. [Epub ahead of print]

View all

resources from our industry partners





We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.